Central ghrelin regulates peripheral lipid metabolism in a growth hormone-independent fashion

Endocrinology

Volumn 150, Issue 10, 2009, Pages 4562-4574

  Sangiao Alvarellos, Susana ^a,b   Vázquez, María J ^b,c   Varela, Luis ^b,c   Nogueiras, Rubén ^b,c   Saha, Asish K ^d   Cordido, Fernando ^a,e   López, Miguel ^b,c,f   Diéguez, Carlos ^b,c,f  

^a UNIVERSITY OF A CORUÑA   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^c Centro de Investigación Biomédica en Red de Cáncer CIBERONC University of Barcelona   (Spain)

^d BOSTON MEDICAL CENTER   (United States)

^e Hospital A Coruna   (Spain)

^f UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE I; FATTY ACID; GHRELIN; GROWTH HORMONE; LIPID; MESSENGER RNA; PROTEIN;

ADIPOSE TISSUE; ADIPOSE TISSUE CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY FAT; CENTRAL NERVOUS SYSTEM; COMORBIDITY; COMPREHENSION; CONTROLLED STUDY; DWARFISM; ENZYME ACTIVITY; FATTY ACID METABOLISM; GROWTH HORMONE DEFICIENCY; HOMEOSTASIS; LEWIS RAT; LIPID METABOLISM; LIPOGENESIS; LIVER; MALE; NEUROENDOCRINE SYSTEM; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WHITE ADIPOSE TISSUE; WILD TYPE;

ADIPOCYTES; ADIPOSE TISSUE, WHITE; ANIMALS; BODY WEIGHT; CENTRAL NERVOUS SYSTEM; EATING; FASTING; GHRELIN; GROWTH HORMONE; HOMEOSTASIS; INJECTIONS, INTRAVENTRICULAR; LIPID METABOLISM; LIVER; MALE; RATS; RATS, INBRED LEW;

EID: 70349326314     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2009-0482     Document Type: Article

References (82)

1. van der Lely AJ 2004 Justified and unjustified use of growth hormone. Postgrad Med J 80:577-580
2. van der Lely AJ 2004 Growth hormone and glucose metabolism: the model of the GH-receptor antagonists. Ann Endocrinol (Paris) 65:81-83
3. Ghigo E, Arvat E, Giordano R, Broglio F, Gianotti L, Maccario M, Bisi G, Graziani A, Papotti M, Muccioli G, Deghenghi R, Camanni F 2001 Biologic activities of growth hormone secretagogues in humans. Endocrine 14:87-93 (Pubitemid 32242907)
4. Jørgensen JO, Vestergaard E, Gormsen L, Jessen N, Nørrelund H, Christiansen JS, Møller N 2005 Metabolic consequences of GH deficiency. J Endocrinol Invest 28:47-51
5. Christiansen JS, Vahl N, Norrelund H, Jørgensen JO 2002 Effects of GH replacement in young patients with childhood onset GH deficiency. Int J Clin Pract Suppl 32-36 (Pubitemid 34987706)
6. Christiansen JS, Jørgensen JO 1991 Beneficial effects of GH replacement therapy in adults. Acta Endocrinol (Copenh) 125:7-13
7. Ghigo E, Aimaretti G, Corneli G 2008 Diagnosis of adult GH deficiency. Growth Horm IGF Res 18:1-16
8. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K 1999 Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660 (Pubitemid 129516334)
9. Kojima M, Hosoda H, Kangawa K 2001 Purification and distribution of ghrelin: the natural endogenous ligand for the growth hormone secretagogue receptor. Horm Res 56(Suppl 1):93-97 (Pubitemid 34062902)
10. Kojima M, Hosoda H, Matsuo H, Kangawa K 2001 Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 12:118-122 (Pubitemid 33714199)
11. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S 2001 A role for ghrelin in the central regulation of feeding. Nature 409:194-198 (Pubitemid 32144284)
12. Zigman JM, Jones JE, Lee CE, Saper CB, Elmquist JK 2006 Expression of ghrelin receptor mRNA in the rat and the mouse brain. J Comp Neurol 494:528-548 (Pubitemid 41791000)
13. Tschöp M, Smiley DL, Heiman ML 2000 Ghrelin induces adiposity in rodents. Nature 407:908-913
14. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG, Dhillo WS, Ghatei MA, Bloom SR 2001 Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 86:5992-5995
15. Wren AM, Small CJ, Abbott CR, Dhillo WS, Seal LJ, Cohen MA, Batterham RL, Taheri S, Stanley SA, Ghatei MA, Bloom SR 2001 Ghrelin causes hyperphagia and obesity in rats. Diabetes 50:2540-2547 (Pubitemid 33642772)
16. Theander-Carrillo C, Wiedmer P, Cettour-Rose P, Nogueiras R, Perez-Tilve D, Pfluger P, Castaneda TR, Muzzin P, Schürmann A, Szanto I, Tschöp MH, Rohner-Jeanrenaud F 2006 Ghrelin action in the brain controls adipocyte metabolism. J Clin Invest 116:1983-1993 (Pubitemid 44033322)
17. López M, Lage R, Saha AK, Pérez-Tilve D, Vázquez MJ, Varela L, Sangiao-Alvarellos S, Tovar S, Raghay K, Rodriguez-Cuenca S, Deoliveira RM, Castañeda T, Datta R, Dong JZ, Culler M, Sleeman MW, Alvarez CV, Gallego R, Lelliott CJ, Carling D, Tschöp MH, Diéguez C, Vidal-Puig A 2008 Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab 7:389-399 (Pubitemid 351618114)
18. Anderson KA, Ribar TJ, Lin F, Noeldner PK, Green MF, Muehlbauer MJ, Witters LA, Kemp BE, Means AR 2008 Hypothalamic CaMKK2 contributes to the regulation of energy balance. Cell Metab 7:377-388 (Pubitemid 351598022)
19. Andrews ZB, Liu ZW, Walllingford N, Erion DM, Borok E, Friedman JM, Tschöp MH, Shanabrough M, Cline G, Shulman GI, Coppola A, Gao XB, Horvath TL, Diano S 2008 UCP2 mediates ghrelin's actionon NPY/AgRP neurons by lowering free radicals. Nature 454:846-851
20. Wren AMSC, Thomas EL, Abbott CR, Ghatei MA, Bell JD, Bloom SR, Continuous subcutaneous administration of ghrelin results in accumulation of adipose tissue, independent of hyperphagia or body weight gain. Proc 23rd Joint Meeting of the British Endocrine Societies, Brighton, UK, 2004, (Abstract OC35)
21. Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DG, Ghatei MA, Bloom SR 2000 The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141:4325-4328 (Pubitemid 30953551)
22. Egecioglu E, Bjursell M, Ljungberg A, Dickson SL, Kopchick JJ, Bergström G, Svensson L, Oscarsson J, Törnell J, Bohlooly-Y M 2006 Growth hormone receptor deficiency results in blunted ghrelin feeding response, obesity, and hypolipidemia in mice. Am J Physiol Endocrinol Metab 290:E317-E325
23. López M, Seoane LM, Tovar S, Nogueiras R, Diéguez C, Señarís R 2004 Orexin-A regulates growth hormone-releasing hormone mRNA content in a nucleus-specific manner and somatostatin mRNA content in a growth hormone-dependent fashion in the rat hypothalamus. Eur J Neurosci 19:2080-2088
24. Charlton HM, Clark RG, Robinson IC, Goff AE, Cox BS, Bugnon C, Bloch BA 1988 Growth hormone-deficient dwarfism in the rat: a new mutation. J Endocrinol 119:51-58 (Pubitemid 18242819)
25. Vázquez MJ, González CR, Varela L, Lage R, Tovar S, Sangiao-Alvarellos S, Williams LM, Vidal-Puig A, Nogueiras R, López M, Diéguez C 2008 Central resistin regulates hypothalamic and peripheral lipid metabolism in a nutritional-dependent fashion. Endocrinology 149:4534-4543
26. Saggerson ED, Greenbaum AL 1970 The regulation of triglyceride synthesis and fatty acid synthesis in rat epididymal adipose tissue. Effects of altered dietary and hormonal conditions. Biochem J 119:221-242
27. Tian WN, Braunstein LD, Apse K, Pang J, Rose M, Tian X, Stanton RC 1999 Importance of glucose-6-phosphate dehydrogenase activity in cell death. Am J Physiol 276:C1121-C1131
28. Tian WN, Braunstein LD, Pang J, Stuhlmeier KM, Xi QC, Tian X, Stanton RC 1998 Importance of glucose-6-phosphate dehydrogenase activity for cell growth. J Biol Chem 273:10609-10617 (Pubitemid 28227673)
29. Karlic H, Lohninger S, Koeck T, Lohninger A 2002 Dietary l-carnitine stimulates carnitine acyltransferases in the liver of aged rats. J Histochem Cytochem 50:205-212 (Pubitemid 34106759)
30. Shin ES, Cho SY, Lee EH, Lee SJ, Chang IS, Lee TR 2006 Positive regulation of hepatic carnitine palmitoyl transferase 1A (CPT1A) activities by soy isoflavones and L-carnitine. Eur J Nutr 45:159-164
31. Antinozzi PA, Segall L, Prentki M, McGarry JD, Newgard CB 1998 Molecular or pharmacologic perturbation of the link between glucose and lipid metabolism is without effect on glucose-stimulated insulin secretion. A re-evaluation of the long-chain acyl-CoA hypothesis. J Biol Chem 273:16146-16154 (Pubitemid 28311386)
32. Gao S, Kinzig KP, Aja S, Scott KA, Keung W, Kelly S, Strynadka K, Chohnan S, Smith WW, Tamashiro KL, Ladenheim EE, Ronnett GV, Tu Y, Birnbaum MJ, Lopaschuk GD, Moran TH 2007 Leptin activates hypothalamic acetyl-CoA carboxylase to inhibit food intake. Proc Natl Acad Sci USA 104:17358-17363 (Pubitemid 350219847)
33. McGarry JD, Stark MJ, Foster DW 1978 Hepatic malonyl-CoA levels of fed, fasted and diabetic rats as measured using a simple radioisotopic assay. J Biol Chem 253:8291-8293
34. López M, Lelliott CJ, Tovar S, Kimber W, Gallego R, Virtue S, Blount M, Vázquez MJ, Finer N, Powles TJ, O'Rahilly S, Saha AK, Diéguez C, Vidal-Puig AJ 2006 Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA. Diabetes 55:1327-1336 (Pubitemid 44195371)
35. Bougneres PF, Artavia-Loria E, Ferre P, Chaussain JL, Job JC 1985 Effects of hypopituitarism and growth hormone replacement therapy on the production and utilization of glucose in childhood. J Clin Endocrinol Metab 61:1152-1157 (Pubitemid 16186718)
36. Zhou Y, He L, Baumann G, Kopchick JJ 1997 Deletion of the mouse GH-binding protein (mGHBP)mRNApolyadenylation and splicing sites does not abolish production of mGHBP. J Mol Endocrinol 19:1-13 (Pubitemid 27345238)
37. Coschigano KT, Holland AN, Riders ME, List EO, Flyvbjerg A, Kopchick JJ 2003 Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 144:3799-3810 (Pubitemid 37088732)
38. Hauck SJ, Bartke A 2001 Free radical defenses in the liver and kidney of human growth hormone transgenic mice: possible mechanisms of early mortality. J Gerontol A Biol Sci Med Sci 56:B153-B162 (Pubitemid 32290880)
39. Hauck SJ, Hunter WS, Danilovich N, Kopchick JJ, Bartke A 2001 Reduced levels of thyroid hormones, insulin, and glucose, and lower body core temperature in the growth hormone receptor/binding protein knockout mouse. Exp Biol Med (Maywood) 226:552-558 (Pubitemid 32524501)
40. Al-Regaiey KA, Masternak MM, Bonkowski M, Sun L, Bartke A 2005 Long-lived growth hormone receptor knockout mice: interaction of reduced insulin-like growth factor i/insulin signaling and caloric restriction. Endocrinology 146:851-860 (Pubitemid 40129843)
41. Hansen I, Tsalikian E, Beaufrere B, Gerich J, Haymond M, Rizza R 1986 Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action. Am J Physiol 250:E269-E273
42. Bramnert M, Segerlantz M, Laurila E, Daugaard JR, Manhem P, Groop L 2003 Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle. J Clin Endocrinol Metab 88:1455-1463 (Pubitemid 36623354)
43. Rosenfalck AM, Maghsoudi S, Fisker S, Jørgensen JO, Christiansen JS, Hilsted J, Vølund AA, Madsbad S 2000 The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults. J Clin Endocrinol Metab 85:4173-4181 (Pubitemid 32063027)
44. Saltiel AR, Kahn CR 2001 Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414:799-806 (Pubitemid 34000783)
45. Kersten S 2001 Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep 2:282-286 (Pubitemid 32401521)
46. Salati LM, Amir-Ahmady B 2001 Dietary regulation of expression of glucose-6-phosphate dehydrogenase. Annu Rev Nutr 21:121-140 (Pubitemid 32695267)
47. Assifi MM, Suchankova G, Constant S, Prentki M, Saha AK, Ruderman NB 2005 AMP-activated protein kinase and coordination of hepatic fatty acid metabolism of starved/carbohydrate-refed rats. Am J Physiol Endocrinol Metab 289:E794-E800 (Pubitemid 41504378)
48. Hardie DG 2008 AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes 32(Suppl 4):S7-S12
49. Foretz M, Ancellin N, Andreelli F, Saintillan Y, Grondin P, Kahn A, Thorens B, Vaulont S, Viollet B 2005 Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes 54:1331-1339 (Pubitemid 40586661)
50. Wang Z, Masternak MM, Al-Regaiey KA, Bartke A 2007 Adipocytokines and the regulation of lipid metabolism in growth hormone transgenic and calorie-restricted mice. Endocrinology 148:2845-2853 (Pubitemid 46984799)
51. To K, Yamaza H, Komatsu T, Hayashida T, Hayashi H, Toyama H, Chiba T, Higami Y, Shimokawa I 2007 Down-regulation of AMP-activated protein kinase by calorie restriction in rat liver. Exp Gerontol 42:1063-1071 (Pubitemid 47633454)
52. Munday MR, Milic MR, Takhar S, Holness MJ, Sugden MC 1991 The short-term regulation of hepatic acetyl-CoA carboxylase during starvation and re-feeding in the rat. Biochem J 280(Pt 3):733-737
53. Gao Q, Horvath TL 2007 Neurobiology of feeding and energy expenditure. Annu Rev Neurosci 30:367-398
54. Kola B, Hubina E, Tucci SA, Kirkham TC, Garcia EA, Mitchell SE, Williams LM, Hawley SA, Hardie DG, Grossman AB, Korbonits M 2005 Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase. J Biol Chem 280:25196-25201 (Pubitemid 40934612)
55. Chen HY, Trumbauer ME, Chen AS, Weingarth DT, Adams JR, Frazier EG, Shen Z, Marsh DJ, Feighner SD, Guan XM, Ye Z, Nargund RP, Smith RG, Van der Ploeg LH, Howard AD, MacNeil DJ, Qian S 2004 Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y and agouti-related protein. Endocrinology 145:2607-2612 (Pubitemid 38686204)
56. Goto M, Arima H, Watanabe M, Hayashi M, Banno R, Sato I, Nagasaki H, Oiso Y 2006 Ghrelin increases neuropeptide Y and agouti-related peptide gene expression in the arcuate nucleus in rat hypothalamic organotypic cultures. Endocrinology 147:5102-5109 (Pubitemid 44790562)
57. Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M, Mori K, Komatsu Y, Usui T, Shimatsu A, Ogawa Y, Hosoda K, Akamizu T, Kojima M, Kangawa K, Nakao K 2000 Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 85:4908-4911 (Pubitemid 32157685)
58. van der Lely AJ, Tschöp M, Heiman ML, Ghigo E 2004 Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25:426-457 (Pubitemid 38780667)
59. Nogueiras R, Tovar S, Mitchell SE, Rayner DV, Archer ZA, Dieguez C, Williams LM 2004 Regulation of growth hormone secretagogue receptor gene expression in the arcuate nuclei of the rat by leptin and ghrelin. Diabetes 53:2552-2558 (Pubitemid 39299261)
60. Barazzoni R, Bosutti A, Stebel M, Cattin MR, Roder E, Visintin L, Cattin L, Biolo G, Zanetti M, Guarnieri G 2005 Ghrelin regulates mitochondrial-lipid metabolism gene expression and tissue fat distribution in liver and skeletal muscle. Am J Physiol Endocrinol Metab 288:E228-E235
61. Andersson U, Filipsson K, Abbott CR, Woods A, Smith K, Bloom SR, Carling D, Small CJ 2004 AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem 279:12005-12008 (Pubitemid 38445761)
62. Kohno D, Sone H, Minokoshi Y, Yada T 2008 Ghrelin raises [Ca2+]i via AMPK in hypothalamic arcuate nucleus NPY neurons. Biochem Biophys Res Commun 366:388-392
63. Kola B, Farkas I, Christ-Crain M, Wittmann G, Lolli F, Amin F, Harvey-White J, Liposits Z, Kunos G, Grossman AB, Fekete C, Korbonits M 2008 The orexigenic effect of ghrelin is mediated through central activation of the endogenous cannabinoid system. PLoS ONE 3:e1797 (Pubitemid 351917350)
64. McGarry JD, Brown NF 1997 The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244:1-14 (Pubitemid 27079689)
65. Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal MS, Hosoda H, Kojima M, Kangawa K, Arima T, Matsuo H, Yada T, Matsukura S 2002 Ghrelin is present in pancreatic α-cells of humans and rats and stimulates insulin secretion. Diabetes 51:124-129 (Pubitemid 34517988)
66. Adeghate E, Ponery AS 2002 Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats. J Neuroendocrinol 14:555-560 (Pubitemid 34679218)
67. Egido EM, Rodriguez-Gallardo J, Silvestre RA, Marco J 2002 Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur J Endocrinol 146:241-244 (Pubitemid 34162918)
68. Lee HM, Wang G, Englander EW, Kojima M, Greeley Jr GH 2002 Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 143:185-190 (Pubitemid 34056418)
69. Dezaki K, Yada T 2004 [Ghrelin in the regulation of glucose and lipid metabolism]. Nippon Rinsho 62(Suppl 9):388-391
70. Broglio F, Arvat E, Benso A, Gottero C, Muccioli G, Papotti M, van der Lely AJ, Deghenghi R, Ghigo E 2001 Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 86:5083-5086 (Pubitemid 33020569)
71. Broglio F, Benso A, Gottero C, Prodam F, Grottoli S, Tassone F, Maccario M, Casanueva FF, Dieguez C, Deghenghi R, Ghigo E, Arvat E 2002 Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans. Clin Endocrinol (Oxf) 57:265-271 (Pubitemid 34989104)
72. Asakawa A, Inui A, Kaga T, Katsuura G, Fujimiya M, Fujino MA, Kasuga M 2003 Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut 52:947-952 (Pubitemid 36765284)
73. Gauna C, Meyler FM, Janssen JA, Delhanty PJ, Abribat T, van Koetsveld P, Hofland LJ, Broglio F, Ghigo E, van der Lely AJ 2004 Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity. J Clin Endocrinol Metab 89:5035-5042 (Pubitemid 39391445)
74. Sun Y, Asnicar M, Saha PK, Chan L, Smith RG 2006 Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice. Cell Metab 3:379-386
75. Wortley KE, del Rincon JP, Murray JD, Garcia K, Iida K, Thorner MO, Sleeman MW 2005 Absence of ghrelin protects against early-onset obesity. J Clin Invest 115:3573-3578 (Pubitemid 43121845)
76. Soares JB, Leite-Moreira AF 2008 Ghrelin, des-acyl ghrelin and obestatin: three pieces of the same puzzle. Peptides 29:1255-1270
77. Gao J, Ghibaudi L, van Heek M, Hwa JJ 2002 Characterization of diet-induced obese rats that develop persistent obesity after 6 months of high-fat followed by 1 month of low-fat diet. Brain Res 936:87-90 (Pubitemid 34461937)
78. Salomon F, Cuneo RC, Umpleby AM, Sonksen PH 1994 Glucose and fat metabolism in adults with growth hormone deficiency. Clin Endocrinol (Oxf) 41:315-322 (Pubitemid 24278325)
79. Freda PU, Reyes CM, Conwell IM, Sundeen RE, Wardlaw SL 2003 Serum ghrelin levels in acromegaly: effects of surgical and long-acting octreotide therapy. J Clin Endocrinol Metab 88:2037-2044
80. Malik IA, English PJ, Ghatei MA, Bloom SR, MacFarlane IA, Wilding JP 2004 The relationship of ghrelin to biochemical and anthropometric markers of adult growth hormone deficiency. Clin Endocrinol (Oxf) 60:137-141
81. Isidro ML, Nemina R, Garcia-Buela J, Sangiao-Alvarellos S, Cordido F 2007 Effect of oral glucose on acylated and total ghrelin secretion in acromegalic patients. Neuro Endocrinol Lett 28:596-603
82. Edén Engström B, Burman P, Holdstock C, Karlsson FA 2003 Effects of growth hormone (GH) on ghrelin, leptin, and adiponectin in GH-deficient patients. J Clin Endocrinol Metab 88:5193-5198 (Pubitemid 37455410)